Gene expression in human chondrocytes in late OA is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy

Article · December 2008with23 Reads
DOI: 10.1136/ard.2008.097139 · Source: PubMed
Abstract
To investigate changes in gene expression in fibrillated and intact human osteoarthritis (OA) cartilage for evidence of an altered chondrocyte phenotype and hypertrophy. Paired osteochondral samples were taken from a high-load site and a low-load site from 25 OA joints and were compared with eight similar paired samples from age-matched controls. Gene expression of key matrix and regulatory genes was analysed by quantitative real-time reverse transcription-polymerase chain reaction on total RNA extracted from the cartilage. There was a major change in chondrocyte gene expression in OA cartilage. SOX9 (38-fold) and aggrecan (4-fold) gene expression were both lower in OA (p<0.001), and collagen I (17-fold) and II (2.5-fold) gene expression were each increased in a subset of OA samples. The major changes in gene expression were similar at the fibrillated high-loaded site and the intact low-loaded site. There was no evidence of a generalised change in OA to proliferative or hypertrophic phenotype as seen in the growth plate, as genes associated with either stage of differentiation were unchanged (PTHrPR), or significantly downregulated (collagen X (14-fold, p<0.002), VEGF (23-fold, p<0.02), BCL-2 (5.6-fold, p<0.001), matrilin-1 (6.5-fold, p<0.001)). In contrast MMP-13 was significantly upregulated in the OA cartilage samples (5.3-fold, p<0.003). The expression of key chondrocyte genes, including aggrecan and SOX9, was decreased in OA cartilage and the changes were similar in both fibrillated high-loaded and intact low-loaded cartilage on the same joint. However, there was no significant upregulation of type X collagen, and other genes associated with chondrocyte further differentiation and hypertrophy.
Article
December 2010 · Alternatives to laboratory animals: ATLA · Impact Factor: 1.59
    Damage and degeneration of articular joints is a major healthcare concern, due to the association of joint disease with ageing, the current strong demographic changes in the proportion of elderly in the population, and the increased incidence of trauma in a sports-active younger population. These joints are biomechanical organs that transmit load between bones in our skeleton, and the... [Show full abstract]
    Article
    March 2015 · NMR in Biomedicine · Impact Factor: 3.04
      Osteoarthritis (OA) is a common multifactorial and heterogeneous degenerative joint disease, and biochemical changes in cartilage matrix occur during the early stages of OA before morphological changes occur. Thus, it is desired to measure regional biochemical changes in the joint. High-resolution magic angle spinning (HRMAS) NMR spectroscopy is a powerful method of observing cartilaginous... [Show full abstract]
      Article
      June 2009 · PROCESS BIOCHEMISTRY · Impact Factor: 2.52
        The past two decades triterpenes have attracted attention because of their pharmacological potential, especially its anti-oxidant activity. The present study was aimed to evaluate the possible protective effects of the triterpene betulin on porcine chondrocytes. For this, the cells were treated with different doses of betulin (0.02, 0.32 and 5.12 μg/mL) and without betulin. Biochemical... [Show full abstract]
        Article
        November 2010 · Equine Veterinary Journal · Impact Factor: 2.37
          Understanding the expression of catabolic and anabolic genes during osteoarthritis progression should help to identify the major mediators of the disease. To compare the cytokine and anabolic marker concentrations in synovium, synovial fluid and cartilage between normal and osteoarthritic joints. Carpi from horses age 2-11 years were used. Tissues were harvested at the time of surgery or... [Show full abstract]
          Article
          June 2010 · International Journal of Experimental Pathology · Impact Factor: 2.17
            Over the past 40 years there have been giant steps forward in our understanding of cellular and molecular biology that have given us the framework by which to understand tissue organization and tissue function on a range of scales. However, although the progress has been great, the more we have discovered, the more we are aware of what we don't yet know. In this article, I would like to flag... [Show full abstract]
            Discover more